You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amyloid Light Chain Amylodosis

Showing 26 - 50 of 5,951
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Neurofilament Light Chain, Glial Fibrillary Acidic Protein Trial (18F-PM-PBB3)

Unknown status
  • Multiple Sclerosis
  • +2 more
  • (no location specified)
Jan 23, 2020

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Neurofilament Light Chain asPotential Marker in Behcet's Disease

Not yet recruiting
  • Behçet
  • serum sample and nerve conduction study and cerebrospinal fluid study
  • (no location specified)
Sep 28, 2023

Biomarkers in Concussion

Not yet recruiting
  • Concussion, Mild
  • +2 more
    • (no location specified)
    Jul 5, 2023

    Amyloidosis Trial in United States (NEOD001, Placebo)

    Terminated
    Has Results
    • Amyloidosis
    • Scottsdale, Arizona
    • +8 more
    Aug 21, 2020

    Hereditary Transthyretin Amyloidosis Trial in Roma (Assessment of disease biomarkers)

    Recruiting
    • Hereditary Transthyretin Amyloidosis
    • Assessment of disease biomarkers
    • Roma, ID, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Jun 26, 2023

    To Evaluate the Clearance Rate of Uremic Toxin by HFR Trial (HFR)

    Not yet recruiting
    • To Evaluate the Clearance Rate of Uremic Toxin by HFR
    • HFR
    • (no location specified)
    Aug 15, 2023

    Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)

    Completed
    Has Results
    • Primary Systemic Amyloidosis
    • Milwaukee, Wisconsin
      Froedtert & Medical College of Wisconsin
    Jun 18, 2021

    Cardiac Amyloidosis Registry Study

    Enrolling by invitation
    • Amyloidosis, Immunoglobulin Light-chain
    • Registry
    • Tucson, Arizona
    • +18 more
    Jun 13, 2022

    AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

    Recruiting
    • AL Amyloidosis
    • Orange, California
    • +5 more
    May 3, 2022

    Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)

    Recruiting
    • Transthyretin Amyloidosis
    • I 124-Evuzamitide
    • New York, New York
      Columbia University Irving Medical Center
    Nov 23, 2022

    Postmenopausal Symptoms, Alzheimer Trial in Ghent (blood take)

    Recruiting
    • Postmenopausal Symptoms
    • Alzheimer Disease
    • blood take
    • Ghent, Belgium
      Ghent university hospital
    Dec 8, 2022

    Cardiac Amyloidosis Screening at Trigger Finger Release

    Completed
    • Amyloidosis
    • +3 more
    • Biopsy
    • Cleveland, Ohio
      Cleveland Clinic
    Dec 21, 2021

    Alzheimer, Family Members Trial in Boston (GENUS)

    Recruiting
    • Alzheimer Disease
    • Family Members
    • GENUS
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 17, 2023

    Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

    Active, not recruiting
    Has Results
    • Primary Systemic Amyloidosis
    • Light Chain Deposition Disease
    • Denver, Colorado
    • +6 more
    Aug 24, 2022

    Heart Failure With Preserved Ejection Fraction, Amyloidosis Cardiac Trial in Taipei (NA, observational study)

    Recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Amyloidosis Cardiac
    • NA, observational study
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 8, 2022

    Neuroimaging in Healthy Aging and Senile Dementia (HASD IND)

    Recruiting
    • Alzheimer Disease
    • [11C]-Pittsburgh Compound B ([11C]PiB)
    • F 18 AV-1451 (Flortaucipir)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 5, 2022

    Cognitive Disorders in Critically Ill Survivors.

    Recruiting
    • Intensive Care Unit Syndrome
    • +2 more
    • Blood analysis
    • Cognitive tests
    • Liège, Belgium
      University Hospital of Liège
    Jul 11, 2023

    Hydrocephalus, Normal Pressure, Biochemical Lesions Head Region, Brain Damage Trial in Hradec Králové (Lumbar puncture, External

    Not yet recruiting
    • Hydrocephalus, Normal Pressure
    • +2 more
    • Lumbar puncture
    • +7 more
    • Hradec Králové, Czechia
      University Hospital Hradec Kralove
    Oct 13, 2023

    Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Alzheimer, Alzheimer, Early Onset, Alzheimer, Late Onset Trial in Cambridge (GENUS device (Active Settings), GENUS device (sham

    Recruiting
    • Alzheimer Disease
    • +5 more
    • GENUS device (Active Settings)
    • GENUS device (sham settings)
    • Cambridge, Massachusetts
      Massachusetts Institute of Technology
    Jan 25, 2023

    Light Chain Amyloidosis Trial (FKC288)

    Not yet recruiting
    • Light Chain Amyloidosis
    • (no location specified)
    Jul 30, 2023

    AL Amyloidosis Trial in Worldwide (Melphalan-Flufenamide (Melflufen), Dexamethasone)

    Terminated
    • AL Amyloidosis
    • Boston, Massachusetts
    • +8 more
    Mar 10, 2022

    Systemic Amyloidosis Trial in Knoxville (124I-p5+14 Injection)

    Completed
    • Systemic Amyloidosis
    • 124I-p5+14 Injection
    • Knoxville, Tennessee
      University of Tennessee Medical Center
    Mar 23, 2022

    Guillain-Barre Syndrome Trial (Efgartigimod Alfa-Fcab, Intravenous Immunoglobulin (IVIg))

    Not yet recruiting
    • Guillain-Barre Syndrome
    • Efgartigimod Alfa-Fcab
    • Intravenous Immunoglobulin (IVIg)
    • (no location specified)
    Jan 17, 2023